Stop Meth Labs and Enhance Patient Access Act of 2014
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 28, 2014)
Stop Meth Labs and Enhance Patient Access Act of 2014 - Amends the Controlled Substances Act to authorize the Attorney General to exempt a scheduled listed chemical product from specified requirements regarding sales quantity, nonliquid forms, and retail transactions upon determining that it is not practical by processes known to be employed by clandestine laboratory operators to use the product in the illicit manufacture of methamphetamine (currently, upon determining that the product cannot be used in the illicit manufacture of methamphetamine).
What just happenedJun 9, 2014
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Who’s behind it
- Introduced in HouseApr 28, 2014
- Jun 9, 2014Committee
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
- May 2, 2014Committee
Referred to the Subcommittee on Health.
- Apr 28, 2014IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Apr 28, 2014IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Apr 28, 2014IntroReferralIntro-H
Introduced in House
- Apr 28, 2014IntroReferral1000
Introduced in House